ADMA BIOLOGICS, INC. Taxes Payable, Current
ADMA BIOLOGICS, INC. (ADMA) had Taxes Payable, Current of $6.22 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-05
- 2026-06-30: Taxes Payable, Current $6.22M.
- 2026-03-31: Taxes Payable, Current $17.12M.
- 2025-12-31: Taxes Payable, Current $8.62M.
- 2025-09-30: Taxes Payable, Current $2.79M.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $6.22M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $17.12M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $8.62M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $2.79M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $6.60M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $3.48M 10-K · filed 2026-02-25 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |